Finance

Lists
Q2 2026 earnings • released • EPS beat +688.28%
See results
RLYB:NASDAQ
Rallybio Corp
$16.70
+3.34%
(+0.54) 1D
Aug 10, 11:28:57 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RLYB...
Open
$16.25
High
$16.97
Low
$16.23
Mkt. cap
88.69M
Avg. vol.
38.46K
Volume
10.20K
52-wk high
$17.57
52-wk low
$3.20
EPS
-$1.37
Beta
-0.90
Shares outstanding
5.31M
No. of employees
9
Open
$16.25
High
$16.97
Low
$16.23
Mkt. cap
88.69M
Avg. vol.
38.46K
Volume
10.20K
52-wk high
$17.57
52-wk low
$3.20
EPS
-$1.37
Beta
-0.90
Shares outstanding
5.31M
No. of employees
9
About Rallybio Corp
CEO-
Employees9
Founded2018
HeadquartersNew Haven, Connecticut, United States
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
Gavin Clark-Gartner
Evercore ISI
Hold
Maintained
$8.00
-52.1%
12/18/2025
Ritu Baral
TD Cowen
Buy
Maintained
-
-
11/10/2025
Last report
Aug 6, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$7.53 / -$1.28
+688.28%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
212.00K
222.00K
212.00K
-
Cost of goods sold
4.14M
3.66M
2.87M
-
Cost of revenue
4.14M
3.66M
2.87M
-
Research and development expenses
-
-
-
758.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.99M
2.98M
5.37M
4.90M
Operating expense
2.99M
2.98M
5.37M
5.65M
Total operating expenses
7.14M
6.63M
8.24M
5.65M
Operating income
-6.92M
-6.41M
-8.03M
-5.65M
Other non operating income
-
-
254.00K
50.42M
EBT including unusual items
16.02M
-5.85M
-8.28M
44.99M
EBT excluding unusual items
-6.46M
-5.85M
-7.57M
44.99M
Income tax expense
-
-
-
1.32M
Effective tax rate
-
-
-
2.94%
Other operating expenses
-
-
-
-
Net income
16.02M
-5.85M
-8.28M
43.66M
Net profit margin
7,554.72%
-2,636.04%
-3,904.72%
-
Earnings per share
2.88
-1.52
-1.46
-0.85
Interest and investment income
462.00K
560.00K
201.00K
218.00K
Interest expense
-
-
-
-
Net interest expenses
462.00K
560.00K
201.00K
218.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.89M
-6.41M
-8.03M
-5.65M
Gain or loss from assets sale
-
-
-
18.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps